Peter S. Kim
Affiliations: | 2014 | Whitehead Institute for Biomedical Research | Merck & Co., Inc. |
2014- | Biochemistry | Stanford University School of Medicine, Palo Alto, CA, United States |
Area:
protein folding, structure of viral envelope proteinsWebsite:
https://profiles.stanford.edu/peterkimGoogle:
"Peter Kim"Bio:
http://www.nasonline.org/member-directory/members/3002006.html
https://chemh.stanford.edu/news/merck-research-labs-chief-peter-kim-join-department-biochemistry
Mean distance: 7.61 | S | N | B | C | P |
Parents
Sign in to add mentorGeorge Paul Hess | research assistant | 1977-1979 | Cornell | |
(Undergraduate research) | ||||
Robert Lesh Baldwin | grad student | 1985 | Stanford | |
(Characterization of protein folding intermediates) |
Children
Sign in to add traineeJon Staley | grad student | MIT | |
Jonathan S. Weissman | grad student | MIT | |
Erin K. O'Shea | grad student | 1992 | MIT |
Pehr Harbury | grad student | 1994 | Stanford Medical School |
Brenda A. Schulman | grad student | 1989-1996 | MIT (Cell Biology Tree) |
Tetiana B. Hryn'ova | grad student | 2006 | Stanford |
Benjamin N Bell | grad student | 2015-2021 | Stanford Medical School |
Yu-Hsien Hwang Fu | post-doc | 2019- | Stanford Medical School |
Duo Xu | post-doc | 2020- | Stanford Medical School (E-Tree) |
Soohyun Kim | post-doc | 2021- | Stanford |
Terrence G. Oas | post-doc | 1987-1990 | MIT |
Kevin J Lumb | post-doc | 1991-1995 | MIT |
Stephen C. Blacklow | post-doc | 1996 | Whitehead Institute (MIT) |
Andrea G. Cochran | post-doc | 1992-1996 | Whitehead Institute for Biomedical Research (MIT) |
Ton N.M. Schumacher | post-doc | 1994-1996 | Whitehead Institute for Biomedical Research (GenetiTree) |
Olga V. Boudker | post-doc | 1999-2001 | Weil Cornell Medical College |
Amy E. Keating | post-doc | 2002 | MIT |
Graham S Erwin | post-doc | 2016-2018 | Stanford |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wu TT, Travaglini KJ, Rustagi A, et al. (2024) Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung. The Journal of Experimental Medicine. 221 |
Xu D, Powell AE, Utz A, et al. (2024) Design of universal Ebola virus vaccine candidates via immunofocusing. Proceedings of the National Academy of Sciences of the United States of America. 121: e2316960121 |
Xu D, Carter JJ, Li C, et al. (2024) Vaccine design via antigen reorientation. Nature Chemical Biology |
Xu D, Powell AE, Utz A, et al. (2023) Design of universal Ebola virus vaccine candidates immunofocusing. Biorxiv : the Preprint Server For Biology |
Hie BL, Shanker VR, Xu D, et al. (2023) Efficient evolution of human antibodies from general protein language models. Nature Biotechnology |
Bruun TJ, Tang S, Erwin G, et al. (2023) Structure-guided stabilization improves the ability of the HIV-1 gp41 hydrophobic pocket to elicit neutralizing antibodies. The Journal of Biological Chemistry. 103062 |
Bell BN, Bruun TUJ, Friedland N, et al. (2023) HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier. Proceedings of the National Academy of Sciences of the United States of America. 120: e2215792120 |
Xu D, Li C, Utz A, et al. (2022) Designing epitope-focused vaccines antigen reorientation. Biorxiv : the Preprint Server For Biology |
Kim S, Filsinger Interrante MV, Kim PS. (2022) Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies. Journal of Virology. e0164722 |
Powell AE, Xu D, Roth GA, et al. (2022) Multimerization of Ebola GPΔmucin on protein nanoparticle vaccines has minimal effect on elicitation of neutralizing antibodies. Frontiers in Immunology. 13: 942897 |